CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints

Detalles Bibliográficos
Autores principales: Kocaata, Z., Simankova, I., Wilke, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Predicting the Effects of the COVID-19 Pandemic and Designing Effective Interventions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832435/
http://dx.doi.org/10.1016/j.jval.2020.08.016
_version_ 1783641836900843520
author Kocaata, Z.
Simankova, I.
Wilke, T.
author_facet Kocaata, Z.
Simankova, I.
Wilke, T.
author_sort Kocaata, Z.
collection PubMed
description
format Online
Article
Text
id pubmed-7832435
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78324352021-01-26 CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints Kocaata, Z. Simankova, I. Wilke, T. Value Health Predicting the Effects of the COVID-19 Pandemic and Designing Effective Interventions Published by Elsevier Inc. 2020-12 2020-12-11 /pmc/articles/PMC7832435/ http://dx.doi.org/10.1016/j.jval.2020.08.016 Text en Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Predicting the Effects of the COVID-19 Pandemic and Designing Effective Interventions
Kocaata, Z.
Simankova, I.
Wilke, T.
CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints
title CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints
title_full CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints
title_fullStr CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints
title_full_unstemmed CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints
title_short CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints
title_sort co1 mapping the landscape of covid-19 clinical trials in the us: assessing the opportunities and gaps in trial designs, interventions and endpoints
topic Predicting the Effects of the COVID-19 Pandemic and Designing Effective Interventions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832435/
http://dx.doi.org/10.1016/j.jval.2020.08.016
work_keys_str_mv AT kocaataz co1mappingthelandscapeofcovid19clinicaltrialsintheusassessingtheopportunitiesandgapsintrialdesignsinterventionsandendpoints
AT simankovai co1mappingthelandscapeofcovid19clinicaltrialsintheusassessingtheopportunitiesandgapsintrialdesignsinterventionsandendpoints
AT wilket co1mappingthelandscapeofcovid19clinicaltrialsintheusassessingtheopportunitiesandgapsintrialdesignsinterventionsandendpoints

Ejemplares similares